Japanese drugmaker Chugai, which is majority owned by Roche, On Friday revealed that Zenyaku Kogyo has obtained regulatory ...

Japanese mid-size drugmaker Otsuka Pharmaceutical announced that it has entered into an exclusive worldwide licensing ...

US healthcare giant Johnson & Johnson has filed a supplemental Biologics License Application with the US Food and Drug ...

Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human ...

Zai Lab and Pfizer have partnered for the commercialization of Xacduro (sulbactam-durlobactam) in China, targeting carbapenem ...

Akeso is awaiting approval from China's medicines regulator for a penpulimab-anlotinib combination therapy for advanced liver ...

Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and ...

AstraZeneca faces challenges in securing full FDA approval for Andexxa, its anticoagulant reversal therapy, due to safety ...

Sino Biopharm has invested $20 million to acquire a 4.91% stake in LaNova Medicines, securing rights to LM-108 and other ...

Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an ...

Merck has over 25 years in MS care, aiming to support patients throughout their journey, including aging with MS. With an ...